A 10-year clinical trial of over 4,200 patients presented at the annual San Antonio symposium last year also found that it was unable to reject the idea ...
News
- SABCS: 10-year study shows targeted radiation can be as effective as whole-breast doses against ...
- Silverback Therapeutics Announces Preclinical Data at 2019 San Antonio Breast Cancer ...
Silverback Therapeutics, Inc., a biopharmaceutical company developing a pipeline of systemically delivered, locally active therapies, announced the ...
- Traders Are Bearish Anixa Biosciences, Inc. (ANIX) After The Stock Formed Bearish Multiple ...
The stock of Anixa Biosciences, Inc. (ANIX) shows a multiple bottoms pattern ... “Anixa Biosciences Announces Presentation at the 2019 San Antonio ...
- Recon: FDA Authorizes First Newborn DMD Screening Test; Amgen, UCB Osteoporosis Drug ...
Pharmaceutical & Biotechnology: Study Results, Filings & Designations ... Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of ... Drug Delivery Technology To Be Presented At San Antonio Breast Cancer ...
- Unplugged: World Cup skiers find creative ways to decompress
She has a computer science degree from Vermont and is now working toward a biomedical engineering degree through the University of Montreal.